Relapsed acute lymphoblastic leukemia (ALL) has remained challenging to treat in children,
with survival rates lagging well behind those observed at initial diagnosis. Although there …

Abstract Treatment outcomes for pediatric patients with acute myeloid leukemia (AML) have
continued to lag behind outcomes reported for children with acute lymphoblastic leukemia …

PURPOSE To develop a clinical practice guideline for systemic antifungal prophylaxis in
pediatric patients with cancer and hematopoietic stem-cell transplantation (HSCT) …

Antifungal prophylaxis can reduce morbidity and mortality from invasive fungal disease
(IFD). However, its use needs to be optimised and appropriately targeted to patients at …

There is a strong argument for the use of antifungal prophylaxis in high‐risk patients given
the significant mortality associated with invasive fungal disease, the late identification of …

Importance Children, adolescents, and young adults with acute myeloid leukemia are at
high risk of life-threatening invasive fungal disease with both yeasts and molds. Objective To …

Welcome to the 30th edition of Nelson's Pediatric Antimicrobial Therapy! The infectious
disease (ID) landscape has certainly continued to change over the past year, with COVID-19 …

Invasive fungal diseases are important clinical problems that are often complicated by
severe illness and therefore the inability to use invasive measures to definitively diagnose …

Children with haematologic malignancies and haematopoietic stem cell transplant recipients
are at high risk for invasive fungal diseases (IFD). There has been an increased number of …

Background Invasive fungal disease (IFD) is a significant complication for children receiving
treatment for leukaemia, contributing to morbidity and mortality. Recent regional paediatric …